Ours has seen many uses, from dark skies to not so dark skies as it has been set up in the Arizona Desert, the summit of Mauna Kea, or various school yards and resorts for public viewing.
Founded in 1997, Vuzix holds 192 patents, patents pending and numerous IP licenses in the video eyewear field.The original NexStar telescopes are great instruments. The Vuzix M-Series boasts the new M4000, M400 and cost-effective M300XL. Vuzix makes and sells two main products - Vuzix Blade Upgraded smart glasses, and the M-series smart glasses.
With a “low upfront capital investment” and overall lower cost per case compared to other technologies, this translates into "greater efficiency in the operating room," which is particularly relevant for US Ambulatory Surgery Centers (ASCs), the firm added. “NextAR's smart delivery tools may improve efficiency in computer-assisted surgery by offering a compact solution that avoids the need for a bulky external detection platform,” noted the company. The Rochester, New York-based company said that the NextAR platform employs a preoperative scan, with proprietary algorithms that create a “personalized biomechanical model for each replacement.” Surgeons equipped with Vuzix Blade Smart Glasses can then access biomechanical visualizations using augmented reality in real-time, without having to divert their eyes from the procedure to glance at a computer screen.
"The Vuzix Smart Glasses are lightweight, comfortable and completely wireless, which means surgeons have complete freedom of movement and can wear them for extended operations," he added. "We're proud to provide the hardware backbone for Medacta's NextAR platform as it continues to branch into new surgical applications which now include knee, shoulder and spine in Europe and knee and shoulder in the United States," Vuzix CEO Paul Travers said in a statement. READ: Vuzix Corporation rises to the ranks of the Russell 20 Indexes In addition, the US Food and Drug Administration (FDA) has also cleared the platform’s shoulder application. A CE Mark indicates that a product fulfills the requirements of relevant European product directives. Having used the Vuzix Blade to complete the first smart glasses-based total knee replacement in the US in 2020, Medacta recently received its CE marking for knee, shoulder, and spine applications for its NextAR Augmented Reality Surgical Platform in Europe. Vuzix Corporation ( NASDAQ:VUZI) (FRA:V7XN), a leading supplier of smart glasses and augmented reality (AR) technology, has announced its market expansion to support the NextAR surgical AR platform developed by Medacta International, one of the world’s largest providers of orthopedic products.
0 kommentar(er)
